Embargoed until 3 p.m. PT/6 p.m. ET, Sunday, Nov. 12, 2017
ANAHEIM, California, Nov.12, 2017 — A combination of reduced sodium intake and the DASH diet lowers blood pressure in adults with hypertension, according to preliminary research presented at the American Heart Association’s Scientific Sessions 2017, a premier global exchange of the latest advances in cardiovascular science for researchers and clinicians.
The study followed 412 adults with systolic blood pressures in four categories: less than 130 mmHg; between 130 and 139 mmHg; between 140 and 159 mmHg; and 150 or higher mmHg. They were either on low-sodium or DASH (Dietary Approaches to Stop Hypertension) diets for four weeks. DASH diets are rich in fruits, vegetables, and whole grains along with low or fat-free dairy, fish, poultry, beans, seeds and nuts. The DASH dietary pattern is promoted by the U.S.-based National Heart, Lung, and Blood Institute and the American Heart Association to control hypertension. While both low-sodium and DASH diets have been reported to help lower high blood pressure, this study examines the effects of combining the two diets in adults with high blood pressure.
Researchers found:
- Participants who cut their sodium intake had lower systolic blood pressure than adults that had high sodium consumption.
- Participants who followed the DASH diet but did not reduce their sodium intake also had lower blood pressure than those with similar sodium intake but not on the DASH diet.
- Participants on the combined diet had lower blood pressure compared to participants with high sodium intake eating their regular diet.
The reduction in blood pressure increased with the severity of hypertension, with participants having systolic blood pressure over 150 mmHg showing the most dramatic difference with the low sodium-DASH diet than those not on the diet. More research is needed to determine if the combination diet has the same effect for adults with systolic blood pressure above 160 mmHg.
Stephen Juraschek, M.D., Ph.D., Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Note: Scientific presentation is 4:30 p.m. PT, Sunday, Nov. 12, 2017.
Presentation location: 211 AB (Main Building)
Additional Resources:
Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.
###
About the American Heart Association
The American Heart Association is devoted to saving people from heart disease and stroke – the two leading causes of death in the world. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat these diseases. The Dallas-based association is the nation’s oldest and largest voluntary organization dedicated to fighting heart disease and stroke. To learn more or to get involved, call 1-800-AHA-USA1, visit heart.org or call any of our offices around the country. Follow us on Facebook and Twitter.
For Media Inquiries and AHA Spokesperson Perspective:
AHA News Media in Dallas: 214-706-1173
AHA News Media Office, Nov. 11-15, 2017 at the Anaheim Convention Center: 714-765-2004.
For Public Inquiries: 800-AHA-USA1 (242-8721)
Leave a Reply